APA (7th ed.) Citation

TD, G., EK, K., LE, R., R, J., MB, G., H, H., & O, T. (2001). The influence of dose of angiotensin I-converting enzyme inhibitor on systolic blood pressure variability in heart failure: A substudy of the Assessment of Treatment with Lisinopril and Survival in heart failure (ATLAS) trial. Blood pressure monitoring, 6(2), 81. https://doi.org/10.1097/00126097-200104000-00003

Chicago Style (17th ed.) Citation

TD, Giles, Kerut EK, Roffidal LE, Jones R, Given MB, Hutchinson H, and Tresznewsky O. "The Influence of Dose of Angiotensin I-converting Enzyme Inhibitor on Systolic Blood Pressure Variability in Heart Failure: A Substudy of the Assessment of Treatment with Lisinopril and Survival in Heart Failure (ATLAS) Trial." Blood Pressure Monitoring 6, no. 2 (2001): 81. https://doi.org/10.1097/00126097-200104000-00003.

MLA (9th ed.) Citation

TD, Giles, et al. "The Influence of Dose of Angiotensin I-converting Enzyme Inhibitor on Systolic Blood Pressure Variability in Heart Failure: A Substudy of the Assessment of Treatment with Lisinopril and Survival in Heart Failure (ATLAS) Trial." Blood Pressure Monitoring, vol. 6, no. 2, 2001, p. 81, https://doi.org/10.1097/00126097-200104000-00003.